Exposure | Gender | Model 1a | Model 2b | Model 3c | |
---|---|---|---|---|---|
Total effect (OR,95%CI, P) | Assoc. Mediator (β,95%CI, P) | Mediation effect (%, P) | Direct effect (OR,95%CI, P) | ||
Past ACS exposure | Male | 0.54 (0.39–0.75, P < 0.001) | 0.63 (0.15–1.11, P = 0.010) | 17.39 P < 0.001 | 0.48 (0.33–0.70, P = 0.002) |
 | Female | 0.69 (0.48–0.99, P = 0.048) | 0.42 (0.08–0.75, P = 0.015) | 24.01 P = 0.48 | 0.94 (0.73–1.22, P = 0.644) |
(1) Prior exposure to training programs | Male | 0.64 (0.42–0.98, P = 0.036) | 0.59 (0.13–1.26, P = 0.041) | 23.63 P = 0.02 | 0.70 (0.45–1.08, P = 0.103) |
 | Female | 0.87 (0.64–1.21, P = 0.417) | 0.57 (0.13–1.02, P = 0.012) | 37.08 P = 0.44 | 0.93 (0.67–1.30, P = 0.667) |
(2) Ever witness ACS in families | Male | 0.64 (0.45–0.90, P = 0.011) | 0.58 (0.04–1.12, P = 0.035) | 18.38 P = 0.04 | 0.58 (0.42–0.80, P < 0.001) |
 | Female | 0.71 (0.52–0.97, P = 0.0313) | 0.43 (0.05–0.80, P = 0.026) | 16.75 P = 0.08 | 0.80 (0.60–1.06, P = 0.111) |
(3) Ever personally experienced ACS | Male | 0.84 (0.56–1.27, P = 0.401) | 0.56 (−0.07–1.19, P = 0.083) | 29.99 P = 0.32 | 0.91 (0.60–1.40, P = 0.674) |
 | Female | 1.11 (0.73–1.72, P = 0.633) | 0.09 (−0.47–0.65, P = 0.757) | 4.4 P = 0.84 | 1.13 (0.74–1.75, P = 0.587) |